Trial Profile
A single dose-escalation study of UR-63325 for the treatment of allergic rhinitis and asthma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Aug 2015
Price :
$35
*
At a glance
- Drugs Seliforant (Primary)
- Indications Allergic rhinitis; Asthma
- Focus Pharmacodynamics; Pharmacokinetics
- 07 Jan 2010 New trial record